Predicting Endoleaks Following Endovascular Aortic Aneurysm Repair Using 18F-Sodium Fluoride
PET-EVAR
The PET-EVAR Study - Predicting Endoleaks Following Endovascular Aortic Aneurysm Repair Using 18F-Sodium Fluoride
1 other identifier
observational
102
1 country
4
Brief Summary
The purpose of the study is to describe Sodium Fluoride uptake (using Positron Emission Tomography-Computed Tomography - PET-CT) following Endovascular Aneurysm Repair (EVAR) and to determine whether Sodium Fluoride PET-CT can predict the development of endoleaks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2021
Longer than P75 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 16, 2020
CompletedFirst Posted
Study publicly available on registry
October 8, 2020
CompletedStudy Start
First participant enrolled
April 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2025
CompletedJuly 3, 2025
June 1, 2025
4 years
September 16, 2020
July 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Microcalcification activity in stented and aneurysmal aorta
Will be measured as 18F Sodium Fluoride binding in the aorta. Uptake will be quantified in Standardised Uptake Values and as a tissue to background ratios.
12 months
Secondary Outcomes (10)
Pattern of microcalcification activity in the stented aorta
12 months
Intensity of microcalcification activity in the stented aorta
12 months
Endoleaks
12 months
Stent graft migration
12 months
Aneurysm sac diameter
12 months
- +5 more secondary outcomes
Other Outcomes (1)
Co-localisation of 18F-Sodium Fluoride with histological changes in aortic tissue
12-36 months
Study Arms (3)
Endoleak Group
Participants with a previous Endovascular Aneurysm Repair (EVAR) who have developed an endoleak
No Endoleak Group
Participants with a previous Endovascular Aneurysm Repair (EVAR) who have not developed an endoleak
Pre-EVAR Group
Participants who have an abdominal aortic aneurysm and who are undergoing an Endovascular Aneurysm Repair as standard of care
Interventions
PET scan using the 18F-Sodium Fluoride radiotracer followed by an attenuation correction CT scan
CT scan to assess aortic morphology and contextualise PET scan
CT scan to assess aortic morphology and the stent graft
This will consist of a telephone consultation with the study participant and review of electronic clinical records
Eligibility Criteria
The study population will consist of individuals with an abdominal aortic aneurysm (AAA). The first part of the study (Study 1 - Case Control Study) will recruit patients with existing EVAR in to two groups: patients that have an endoleak or related complication (endoleak group, n = 22) and those that have remained complication-free (no endoleak group, n = 22). We will also prospectively recruit patients who are yet to receive EVAR or fenestrated EVAR (pre-EVAR group, n = 100) for the (Study 2 - Cohort Study). There will be four patient identification centres from which patients will be recruited: NHS Lothian, NHS Lanarkshire, NHS Greater Glasgow and Clyde, and NHS Tayside.
You may qualify if:
- A diagnosis of AAA as defined by the European Society of Vascular Surgery guidelines on the management of aorto-iliac artery aneurysms, and having undergone endovascular repair within the recommended Instructions For Use (IFU) by the manufacturer. \['Endoleak' and 'No Endoleak groups only\]
- Complication will be defined as any type of endoleak or stent graft migration \['Endoleak' group only\].
- A diagnosis of AAA requiring endovascular repair OR a diagnosis of juxtarenal AAA requiring fenestrated endovascular aneurysm repair as defined by the European Society of Vascular surgery guidelines on the management of aorto-iliac artery aneurysms and planned EVAR or fenestrated EVAR surgery. \['pre-EVAR' group only\]
- Minimum age: 50 years. No maximum age.
- Retain capacity for informed consent
You may not qualify if:
- The inability of patients to undergo PET/CT scanning
- Chronic kidney disease (eGFR ≤ 30 mL/min/1.73 m2)
- Major or untreated cancer
- Pregnancy
- Allergy or contra-indication to iodinated contrast
- Inability or unwillingness to give informed consent
- Life-expectancy of less than two years
- Known history of connective tissue disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Edinburghlead
- NHS Lothiancollaborator
- NHS Greater Glasgow and Clydecollaborator
- NHS Lanarkshirecollaborator
- NHS Taysidecollaborator
Study Sites (4)
Ninewells Hospital
Dundee, DD2 1SG, United Kingdom
University Hospital Hairmyres
East Kilbride, G75 8RG, United Kingdom
Royal Infirmary of Edinburgh
Edinburgh, EH16 4SB, United Kingdom
Queen Elizabeth University Hospital
Glasgow, G51 4TF, United Kingdom
Related Publications (2)
Debono S, Nash J, Fletcher AJ, Syed M, van Beek EJR, Williams MC, Falah O, Tambyraja A, Dweck MR, Newby DE, Forsythe RO. Aortic sodium [18F]fluoride uptake following endovascular aneurysm repair. Heart. 2023 Oct 26;109(22):1677-1682. doi: 10.1136/heartjnl-2023-322514.
PMID: 37164479RESULTDebono S, Nash J, Tambyraja AL, Newby DE, Forsythe RO. Endovascular repair for abdominal aortic aneurysms. Heart. 2021 Nov;107(22):1783-1789. doi: 10.1136/heartjnl-2020-318288. Epub 2021 Mar 4.
PMID: 33674354DERIVED
Biospecimen
Aortic tissue specimens obtained from individuals undergoing open surgical repair will be studied histologically, using autoradiography and micro-PET/CT.
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Samuel Debono
University of Edinburgh
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 16, 2020
First Posted
October 8, 2020
Study Start
April 1, 2021
Primary Completion
March 31, 2025
Study Completion
March 31, 2025
Last Updated
July 3, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share
There are no plans for individual participant data sharing.